LinkinVAX Completes First Batch Production of "PanCov", Its Next Generation Multi-variant Vaccine Against Covid and Other Coronaviruses
PanCov is born from a collaboration with French GTP BIOWAYS and European FAREVA to provide effective, rapid and innovative solutions to unmet healthcare needs.PARIS & TOULOUSE, France--(BUSINESS WIRE)--LinKinVax, a clinical-stage biotechnology company, announced the manufacture and bottling of a GMP batch of its nex...
Source: pharmiweb.com